Display options
Cite
Matejcic M, Saunders EJ, Dadaev T, et al. Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nat Commun. 2019;10(1):382doi: 10.1038/s41467-019-08293-z.
Matejcic, M., Saunders, E. J., Dadaev, T., Brook, M. N., Wang, K., Sheng, X., Olama, A. A. A., Schumacher, F. R., Ingles, S. A., Govindasami, K., Benlloch, S., Berndt, S. I., Albanes, D., Koutros, S., Muir, K., Stevens, V. L., Gapstur, S. M., Tangen, C. M., Batra, J., Clements, J., Gronberg, H., Pashayan, N., Schleutker, J., Wolk, A., West, C., Mucci, L., Kraft, P., Cancel-Tassin, G., Sorensen, K. D., Maehle, L., Grindedal, E. M., Strom, S. S., Neal, D. E., Hamdy, F. C., Donovan, J. L., Travis, R. C., Hamilton, R. J., Rosenstein, B., Lu, Y. J., Giles, G. G., Kibel, A. S., Vega, A., Bensen, J. T., Kogevinas, M., Penney, K. L., Park, J. Y., Stanford, J. L., Cybulski, C., Nordestgaard, B. G., Brenner, H., Maier, C., Kim, J., Teixeira, M. R., Neuhausen, S. L., De Ruyck, K., Razack, A., Newcomb, L. F., Lessel, D., Kaneva, R., Usmani, N., Claessens, F., Townsend, P. A., Gago-Dominguez, M., Roobol, M. J., Menegaux, F., Khaw, K. T., Cannon-Albright, L. A., Pandha, H., Thibodeau, S. N., Schaid, D. J., Wiklund, F., Chanock, S. J., Easton, D. F., Eeles, R. A., Kote-Jarai, Z., Conti, D. V., & Haiman, C. A. (2019). Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nature communications, 10(1), 382. https://doi.org/10.1038/s41467-019-08293-z
Matejcic, Marco, et al. "Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry." Nature communications vol. 10,1 (2019): 382. doi: https://doi.org/10.1038/s41467-019-08293-z
Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, Stevens VL, Gapstur SM, Tangen CM, Batra J, Clements J, Gronberg H, Pashayan N, Schleutker J, Wolk A, West C, Mucci L, Kraft P, Cancel-Tassin G, Sorensen KD, Maehle L, Grindedal EM, Strom SS, Neal DE, Hamdy FC, Donovan JL, Travis RC, Hamilton RJ, Rosenstein B, Lu YJ, Giles GG, Kibel AS, Vega A, Bensen JT, Kogevinas M, Penney KL, Park JY, Stanford JL, Cybulski C, Nordestgaard BG, Brenner H, Maier C, Kim J, Teixeira MR, Neuhausen SL, De Ruyck K, Razack A, Newcomb LF, Lessel D, Kaneva R, Usmani N, Claessens F, Townsend PA, Gago-Dominguez M, Roobol MJ, Menegaux F, Khaw KT, Cannon-Albright LA, Pandha H, Thibodeau SN, Schaid DJ, Wiklund F, Chanock SJ, Easton DF, Eeles RA, Kote-Jarai Z, Conti DV, Haiman CA. Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nat Commun. 2019 Jan 17;10(1):382. doi: 10.1038/s41467-019-08293-z. PMID: 30655571; PMCID: PMC6336778.
Copy Download .nbib Format: NLM
Share it on

Nat Commun. 2019 Jan 17;10(1):382. doi: 10.1038/s41467-019-08293-z.

Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

Nature communications

Marco Matejcic, Edward J Saunders, Tokhir Dadaev, Mark N Brook, Kan Wang, Xin Sheng, Ali Amin Al Olama, Fredrick R Schumacher, Sue A Ingles, Koveela Govindasami, Sara Benlloch, Sonja I Berndt, Demetrius Albanes, Stella Koutros, Kenneth Muir, Victoria L Stevens, Susan M Gapstur, Catherine M Tangen, Jyotsna Batra, Judith Clements, Henrik Gronberg, Nora Pashayan, Johanna Schleutker, Alicja Wolk, Catharine West, Lorelei Mucci, Peter Kraft, Géraldine Cancel-Tassin, Karina D Sorensen, Lovise Maehle, Eli M Grindedal, Sara S Strom, David E Neal, Freddie C Hamdy, Jenny L Donovan, Ruth C Travis, Robert J Hamilton, Barry Rosenstein, Yong-Jie Lu, Graham G Giles, Adam S Kibel, Ana Vega, Jeanette T Bensen, Manolis Kogevinas, Kathryn L Penney, Jong Y Park, Janet L Stanford, Cezary Cybulski, Børge G Nordestgaard, Hermann Brenner, Christiane Maier, Jeri Kim, Manuel R Teixeira, Susan L Neuhausen, Kim De Ruyck, Azad Razack, Lisa F Newcomb, Davor Lessel, Radka Kaneva, Nawaid Usmani, Frank Claessens, Paul A Townsend, Manuela Gago-Dominguez, Monique J Roobol, Florence Menegaux, Kay-Tee Khaw, Lisa A Cannon-Albright, Hardev Pandha, Stephen N Thibodeau, Daniel J Schaid, Fredrik Wiklund, Stephen J Chanock, Douglas F Easton, Rosalind A Eeles, Zsofia Kote-Jarai, David V Conti, Christopher A Haiman

Affiliations

  1. Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, 90033, USA.
  2. The Institute of Cancer Research, London, SW7 3RP, UK.
  3. Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, CB1 8RN, UK.
  4. Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK.
  5. Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, 44106-7219, USA.
  6. Seidman Cancer Center, University Hospitals, Cleveland, OH, 44106, USA.
  7. Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, 20892, USA.
  8. Institute of Population Health, University of Manchester, Manchester, M13 9PL, UK.
  9. Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
  10. Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA.
  11. SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
  12. Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, Brisbane, QLD, 4059, Australia.
  13. Translational Research Institute, Brisbane, QLD, 4102, Australia.
  14. Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77, Stockholm, Sweden.
  15. Centre for Cancer Genetic Epidemiology, Department of Oncology, Strangeways Laboratory, University of Cambridge, Cambridge, CB1 8RN, UK.
  16. Department of Applied Health Research, University College London, London, WC1E 7HB, UK.
  17. Department of Medical Biochemistry and Genetics, Institute of Biomedicine, University of Turku, FI-20014, Turku, Finland.
  18. Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, 20521, Turku, Finland.
  19. BioMediTech, University of Tampere, 33520, Tampere, Finland.
  20. Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
  21. Division of Cancer Sciences, Manchester Academic Health Science Centre, Radiotherapy Related Research, Manchester NIHR Biomedical Research Centre, The Christie Hospital NHS Foundation Trust, University of Manchester, Manchester, M13 9PL, UK.
  22. Department of Epidemiology, Harvard School of Public Health, Boston, MA, 02115, USA.
  23. Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.HChan School of Public Health, Boston, MA, 02115, USA.
  24. GRC N°5 ONCOTYPE-URO, UPMC Univ Paris 06, Tenon Hospital, F-75020, Paris, France.
  25. CeRePP, Tenon Hospital, F-75020, Paris, France.
  26. Department of Molecular Medicine, Aarhus University Hospital, 8200, Aarhus N, Denmark.
  27. Department of Clinical Medicine, Aarhus University, 8200, Aarhus N, Denmark.
  28. Department of Medical Genetics, Oslo University Hospital, 0424, Oslo, Norway.
  29. Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  30. Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK.
  31. Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK.
  32. Nuffield Department of Surgical Sciences, University of Oxford, Oxford, OX1 2JD, UK.
  33. School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
  34. Cancer Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
  35. Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, ON, M5G 2M9, Canada.
  36. Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
  37. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029-5674, USA.
  38. Centre for Molecular Oncology, Barts Cancer Institute, John Vane Science Centre, Queen Mary University of London, London, EC1M 6BQ, UK.
  39. Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, 3004, Australia.
  40. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, 3010, Australia.
  41. Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, 02115, USA.
  42. Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, 15706, Santiago de Compostela, Spain.
  43. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Columbia, SC, 29208, USA.
  44. Centre for Research in Environmental Epidemiology (CREAL), Barcelona Institute for Global Health (ISGlobal), 08003, Barcelona, Spain.
  45. CIBER Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.
  46. IMIM (Hospital del Mar Research Institute), 08003, Barcelona, Spain.
  47. Universitat Pompeu Fabra (UPF), 08002, Barcelona, Spain.
  48. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 02184, USA.
  49. Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, 33612, USA.
  50. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109-1024, USA.
  51. Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, 98195, USA.
  52. International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 70-115, Szczecin, Poland.
  53. Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark.
  54. Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200, Copenhagen, Denmark.
  55. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany.
  56. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany.
  57. Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120, Heidelberg, Germany.
  58. Institute for Human Genetics, University Hospital Ulm, 89075, Ulm, Germany.
  59. Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  60. Department of Genetics, Portuguese Oncology Institute of Porto, 4200-072, Porto, Portugal.
  61. Biomedical Sciences Institute (ICBAS), University of Porto, 4050-313, Porto, Portugal.
  62. Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, 91010, USA.
  63. Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, B-9000, Gent, Belgium.
  64. Faculty of Medicine, Department of Surgery, University of Malaya, 50603, Kuala Lumpur, Malaysia.
  65. Department of Urology, University of Washington, Seattle, WA, 98195, USA.
  66. Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, D-20246, Hamburg, Germany.
  67. Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, 1431, Sofia, Bulgaria.
  68. Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, T6G 1Z2, Canada.
  69. Division of Radiation Oncology, Cross Cancer Institute, Edmonton, AB, T6G 1Z2, Canada.
  70. Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, BE-3000, Leuven, Belgium.
  71. Manchester Cancer Research Centre, Faculty of Biology Medicine and Health, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, M13 9WL, UK.
  72. Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, 15706, Santiago de Compostela, Spain.
  73. Moores Cancer Center, University of California San Diego, La Jolla, CA, 92037, USA.
  74. Department of Urology, Erasmus University Medical Center, 3015 CE, Rotterdam, The Netherlands.
  75. Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, 94807, Villejuif Cédex, France.
  76. Clinical Gerontology Unit, University of Cambridge, Cambridge, CB2 2QQ, UK.
  77. Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA.
  78. George EWahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, 84148, USA.
  79. The University of Surrey, Guildford, Surrey, GU2 7XH, UK.
  80. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.
  81. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, 55905, USA.
  82. Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
  83. Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, 90033, USA. [email protected].

PMID: 30655571 PMCID: PMC6336778 DOI: 10.1038/s41467-019-08293-z

Abstract

The original version of this Article contained an error in the spelling of the author Manuela Gago-Dominguez, which was incorrectly given as Manuela G. Dominguez. This has now been corrected in both the PDF and HTML versions of the Article.

Publication Types

Grant support